{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:36:42Z","timestamp":1784867802739,"version":"3.55.0"},"reference-count":26,"publisher":"BMJ","issue":"12","funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Murdoch Childrens Research Institute"},{"name":"Royal Childrens Hospital Foundation"},{"DOI":"10.13039\/501100003747","name":"Department of Health, State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003747","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Avant Doctor In Training Scholarship"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Emerg Med J"],"accepted":{"date-parts":[[2017,8,31]]},"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Children with moderate\/severe cellulitis requiring intravenous antibiotics are usually admitted to hospital. Admission avoidance is attractive but there are few data in children. We implemented a new pathway for children to be treated with intravenous antibiotics at home and aimed to describe the characteristics of patients treated on this pathway and in hospital and to evaluate the outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This is a prospective, observational cohort study of children aged 6\u2009months\u201318 years attending the ED with uncomplicated moderate\/severe cellulitis in March 2014\u2013January 2015. Patients received either intravenous ceftriaxone at home or intravenous flucloxacillin in hospital based on physician discretion. Primary outcome was treatment failure defined as antibiotic change within 48\u2009hours due to inadequate clinical improvement or serious adverse events. Secondary outcomes include duration of intravenous antibiotics and complications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>115 children were included: 47 (41%) in the home group and 68 (59%) in the hospital group (59 hospital-only, 9 transferred home during treatment). The groups had similar clinical features. 2\/47 (4%) of the children in the home group compared with 8\/59 (14%) in the hospital group had treatment failure (P=0.10). Duration of intravenous antibiotics (median 1.9 vs 1.8 days, P=0.31) and complications (6% vs 10%, P=0.49) were no different between groups. Home treatment costs less, averaging $A1166 (\u00a3705) per episode compared with $A2594 (\u00a31570) in hospital.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Children with uncomplicated cellulitis may be able to avoid hospital admission via a home intravenous pathway. This approach has the potential to provide cost and other benefits of home treatment.<\/jats:p><\/jats:sec>","DOI":"10.1136\/emermed-2017-206829","type":"journal-article","created":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T00:50:12Z","timestamp":1507164612000},"page":"780-785","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["Evaluating an admission avoidance pathway for children in the emergency department: outpatient intravenous antibiotics for moderate\/severe cellulitis"],"prefix":"10.1136","volume":"34","author":[{"given":"Laila F","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy M","family":"Hopper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom G","family":"Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope A","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz E","family":"Babl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,10,4]]},"reference":[{"key":"2024052702025178000_34.12.780.1","first-page":"216","article-title":"Home intravenous antimicrobial service--twelve months experience in Christchurch","volume":"115","author":"Chambers","year":"2002","journal-title":"N Z Med J"},{"key":"2024052702025178000_34.12.780.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2012.01.016"},{"key":"2024052702025178000_34.12.780.3","doi-asserted-by":"publisher","DOI":"10.1086\/420939"},{"key":"2024052702025178000_34.12.780.4","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/TP.0b013e31816a3267","article-title":"Case-control comparison of at-home and hospital care for allogeneic hematopoietic stem-cell transplantation: the role of oral nutrition","volume":"85","author":"Svahn","year":"2008","journal-title":"Transplantation"},{"key":"2024052702025178000_34.12.780.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2214.2005.00550.x"},{"key":"2024052702025178000_34.12.780.6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2012.02775"},{"key":"2024052702025178000_34.12.780.7","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/pbc.24474","article-title":"Hospital-based home care for children with cancer: feasibility and psychosocial impact on children and their families","volume":"60","author":"Hansson","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"2024052702025178000_34.12.780.8","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25012"},{"key":"2024052702025178000_34.12.780.9","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/j.annemergmed.2016.08.201","article-title":"188 inpatient versus outpatient management of infants 29-60 days with presumed pyelonephritis at low risk for bacteremia: a cost analysis","volume":"68","author":"Sarvis","year":"2016","journal-title":"Ann Emerg Med"},{"key":"2024052702025178000_34.12.780.10","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/INF.0000000000000938","article-title":"Blood cultures in cellulitis are not cost effective and should prompt investigation for an alternative focus","volume":"35","author":"Bryant","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"2024052702025178000_34.12.780.11","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000768"},{"key":"2024052702025178000_34.12.780.12","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-1384"},{"key":"2024052702025178000_34.12.780.13","doi-asserted-by":"publisher","DOI":"10.1086\/340056"},{"key":"2024052702025178000_34.12.780.14","doi-asserted-by":"publisher","DOI":"10.1177\/000992280604500306"},{"key":"2024052702025178000_34.12.780.15","first-page":"216","article-title":"Palatability of liquid anti-infectives: clinician and student perceptions and practice outcomes","volume":"12","author":"Gee","year":"2007","journal-title":"J Pediatr Pharmacol Ther"},{"key":"2024052702025178000_34.12.780.16","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-198501000-00008"},{"issue":"3 Pt 2","key":"2024052702025178000_34.12.780.17","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1542\/peds.82.3.486","article-title":"Once-daily administration of ceftriaxone for the treatment of selected serious bacterial infections in children","volume":"82","author":"Frenkel","year":"1988","journal-title":"Pediatrics"},{"key":"2024052702025178000_34.12.780.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.2007.01236.x"},{"key":"2024052702025178000_34.12.780.19","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00006454-198909000-00008","article-title":"Randomized comparative study of ampicillin\/sulbactam vs. ceftriaxone for treatment of soft tissue and skeletal infections in children","volume":"8","author":"Kulhanjian","year":"1989","journal-title":"Pediatr Infect Dis J"},{"key":"2024052702025178000_34.12.780.20","doi-asserted-by":"publisher","DOI":"10.1097\/PEC.0b013e318248b19b"},{"key":"2024052702025178000_34.12.780.21","doi-asserted-by":"crossref","unstructured":"Ibrahim LF , Hopper SM , Babl FE , et al . Who can safely have antibiotics at home? a prospective observational study in children with moderate\/severe cellulitis. Pediatr Infect Dis J 2015.doi:10.1097\/INF.0000000000000992","DOI":"10.1097\/INF.0000000000000992"},{"key":"2024052702025178000_34.12.780.22","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu655"},{"key":"2024052702025178000_34.12.780.23","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu743"},{"key":"2024052702025178000_34.12.780.24","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04531-14"},{"key":"2024052702025178000_34.12.780.25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.diagmicrobio.2015.03.002","article-title":"Ceftriaxone susceptibility of oxacillin-susceptible staphylococcus aureus from patients with prosthetic joint infection","volume":"82","author":"Greenwood-Quaintance","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2024052702025178000_34.12.780.26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2165\/00044011-199612050-00001","article-title":"A randomised comparative study of once-daily ceftriaxone and 6-hourly flucloxacillin in the treatment of moderate to severe cellulitis - Clinical efficacy, safety and pharmacoeconomic implications","volume":"12","author":"Vinen","year":"1996","journal-title":"Clinical Drug Investigation"}],"container-title":["Emergency Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/emermed-2017-206829","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T09:03:20Z","timestamp":1716800600000},"score":1,"resource":{"primary":{"URL":"https:\/\/emj.bmj.com\/lookup\/doi\/10.1136\/emermed-2017-206829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,4]]},"references-count":26,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,11,23]]},"published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.1136\/emermed-2017-206829"],"URL":"https:\/\/doi.org\/10.1136\/emermed-2017-206829","relation":{},"ISSN":["1472-0205","1472-0213"],"issn-type":[{"value":"1472-0205","type":"print"},{"value":"1472-0213","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,4]]}}}